Browse Category

Pharmaceuticals 21 June 2026 - 5 July 2026

Eli Lilly Shares Approach Record High While Retatrutide Legal Action Secures New Obesity Hope
Novo Nordisk (CPH:NOVO-B) rises, but volume stays light ahead of August results

Novo Nordisk (CPH:NOVO-B) rises, but volume stays light ahead of August results

Novo Nordisk A/S finished the week with a smaller rally than the rest of the Danish market. B shares closed Friday at DKK 326.90, dropping 1.54% on the day but still up 2.8% for the week. The OMX Copenhagen 25 gained 5.5% in the same period, so the stock lagged the benchmark by about 2.6 percentage points. Novo’s Friday volume hit 2.58 million shares, or 45% of its 65-day average, according to MarketWatch. For the week, turnover was 19.23 million shares, down from 25.66 million a week earlier. Investing.com reported the OMXC25 at 1,899.12 on Friday, up from 1,800.88 the previous week.
AbbVie moves to acquire Apogee in $10.9 billion bet on immunology

AbbVie moves to acquire Apogee in $10.9 billion bet on immunology

AbbVie said Monday it’s buying Apogee Therapeutics for $10.9 billion in cash, making this its largest deal since 2019. The company is looking to strengthen its immunology pipeline with Apogee’s long-acting immune-disease drugs. AbbVie and Apogee put out a joint release on the agreement, according to a securities filing. They expect the deal to close in the third quarter of 2026.
1 3 4 5 6 7 47
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 88 / 100
#5 BUY THE RESET

Ferguson

NYSE: FERG 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.